OECHSLER significantly expands worldwide production capacities for medical products

Global Expansion of Manufacturing Capacity

Learn more about OECHSLERhealth

  • Polymer technology specialist invests an amount in the mid single-digit million range in global expansion of its cleanroom facilities
  • Starting point for a comprehensive growth offensive in its healthcare business to exceed the sales threshold of 100 million euros
  • OECHSLER has more than 30 years of experience in medical technology and offers a broad technology portfolio

Ansbach, Germany, December 06, 2022 --- OECHSLER AG ("OECHSLER"), a leading polymer technology group with a global presence and headquarters in Ansbach, is significantly expanding its worldwide production capacities for medical products. Over the next two years, the polymer technology specialist will be investing an amount in the mid-single-digit million euro range in the global expansion of new cleanroom space in ISO Class 7 and 8, respectively GMP Class C & D. At its headquarters in Ansbach alone, OECHSLER will be increasing cleanroom capacity by 50 percent by the spring of next year -- part of which will be in ISO 7. Additional cleanroom capacity at its sites in Mexico and Romania will be added over the next few years.

The company is thus launching a  large-scale growth offensive to expand its customer and product portfolio, given the rising demand in the medical technology sector. By 2028, OECHSLER aims to exceed the threshold of 100 million euros sales in its medical products business. Here, the technology company sees significant growth potential particularly in drug delivery systems and diagnostics product categories.

Full-service provider with a high level of industrialization expertise and innovative strength    

Partnerships are an essential part of the growth strategy. Already since the middle of the year, the polymer technology specialist has been working with new customers. OECHSLER supports its customers throughout the entire product development process, from concept development to successful market launch and series production. One of these new customers is the Munich-based medical technology start-up Pulmotree. Together, the partners are developing a new generation of smart, portable inhalers. Here, OECHSLER supports the design of the modern medical device in line with series production.

OECHSLER has extensive experience in the manufacture of medical technology products. For over 30 years, the company has been producing inhalers, blood glucose meters, pipettes, and catheters for numerous renowned pharmaceutical companies worldwide. In particular, the high standards of quality and precision and the company's international presence are decisive for this long-standing success. The polymer technology specialist has consistently internationalized its production network over the past decades and has sites in China, Vietnam, Germany, Romania and Mexico. Another relevant success factor is OECHSLER's broad technology portfolio, which ranges from polymer, metal, and ceramic injection molding to additive manufacturing and creating complex assemblies made of polymers and electronic components.

Global demand for medical products continues to increase significantly

The global healthcare market, worth more than one trillion euros, is expected to grow significantly in the coming years. The trend is toward home treatment; people want to be able to carry out medically necessary treatments as individually and independently as possible. In the inhaler category alone, market research institutes forecast an average annual growth of 7 percent until 2030. For blood glucose meters, the expected annual growth is even 11 percent. Worldwide, about 500 million people already suffer from diabetes, and the trend is rising.

Dr. Claudius M. Kozlik, CEO of OECHSLER, underlined the increasing importance of the healthcare business for the company: "Our technology portfolio as a full-service provider and our international production sites enable us to offer our customers customized manufacturing solutions for high-quality medical devices -- this is how we have established ourselves as a reliable partner in medical technology over more than three decades. We are building on this experience. Following the expansion and development of the Sporting Goods business unit and the growing importance of additive manufacturing, we are consistently continuing our company's growth course with the expansion of cleanroom capacities."

Felix Hess, Vice President of Sales Healthcare at OECHSLER, added: "The growing global market for medical devices offers great opportunities for OECHSLER. Our decades of experience in the market and our high standards of quality and precision are an excellent basis for participating in this growth. We are continuously optimizing our processes in order to efficiently support the global requirements of the industry as a strong partner, thus preparing our organization for the additional demand in the coming years."

Build on trust

Your Turnkey Partner for Healthcare

OECHSLER is a leading and deep-rooted supplier of polymer and powder manufacturing processes. Services to our healthcare customers are based on our profound experience, fascination for our production technologies, and passion for innovation. The longstanding trust of our blue chip customers demonstrates the reliability and performance of OECHSLER.

Learn more about OECHSLERhealth


  • News 11.07.2024

Milestone Reached: OECHSLER’s Successful Implementation of the Supply Chain Due Diligence Act

OECHSLER successfully implemented the Supply Chain Due Diligence Act.

Read now
  • News 30.04.2024

OECHSLER AG appoints new Chief Operating Officer (COO)

Alexander Wortberg will be responsible for Production and Human Resources worldwide as a member of the Management Board from June 1, 2024.

Read now
  • News 14.03.2024

Innovations made in Bavaria: Minister of Economic Affairs Hubert Aiwanger visits OECHSLER AG

Bavaria's Minister of Economic Affairs Hubert Aiwanger visits OECHSLER AG in Ansbach.

Read now
  • News 13.02.2024

OECHSLER AG has initiated a global transformation program to ensure a secure future.

OECHSLER is reorganizing its group structure into three business units with a central production responsibility.

Read now
  • News 16.01.2024

OECHSLER AG appoints new Spokesman of the Executive Board

Karl Ostler has been appointed Spokesman of the Executive Board of the Franconian technology company with effect from January 1, 2024.

Read now
  • News 07.12.2023

OECHSLER cooperates with the Ansbach University of Applied Sciences

Prof. Dr. Roland Schnurpfeil tells us more about the collaboration with OECHSLER and the vision that both partners share.

Read now
  • News 12.09.2023

OECHSLER Unveils OECHSLERhealth: A Global Brand for its Medical Technology Business Unit

Read now
  • News 21.08.2023

Flexible Manufacturing with 3D Printing: Streamlining Production Processes for the Future

Unlocking Manufacturing Agility with AMFG: Streamlining Production Processes for the Future

Read now
  • News 24.07.2023

Science Based Targets initiative

OECHSLER have committed to set a science-based target with the Science Based Targets initiative

Read now
  • News 21.07.2023

OECHSLER Satisfaction Survey 2022

OECHSLER reported 5.21 out of 6 overall satisfaction in 2023 satisfaction survey

Read now
  • News 10.07.2023

Introducing OECHSLER's Sustainable Milestone: A New PV Plant in Weissenburg!

OECHSLER installed new PV Plant in Weissenburg.

Read now
  • News 30.06.2023

OECHSLER AG Appoints Sales Expert to the Board

We welcome Raik Lüder to OECHSLER.

Read now

Register for our Newsletter.

Gain exclusive insights on our latest innovations, corporate news and upcoming events.